Victory Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $92.1M | Buy |
1,367,932
+151,327
| +12% | +$10.1M | 0.05% | 348 |
|
|
2026
Q1 | $76.4M | Buy |
1,216,605
+149,412
| +14% | +$10.4M | 0.05% | 379 |
|
|
2025
Q4 | $70.8M | Sell |
1,067,193
-14,026
| -1% | -$907K | 0.04% | 409 |
|
|
2025
Q3 | $72.8M | Buy |
1,081,219
+518,180
| +92% | +$41M | 0.04% | 401 |
|
|
2025
Q2 | $49.1M | Sell |
563,039
-166,626
| -23% | -$13.1M | 0.03% | 559 |
|
|
2025
Q1 | $49.8M | Buy |
729,665
+169,494
| +30% | +$13.8M | 0.05% | 460 |
|
|
2024
Q4 | $43.6M | Sell |
560,171
-10,436
| -2% | -$773K | 0.04% | 512 |
|
|
2024
Q3 | $38.3M | Sell |
570,607
-419,081
| -42% | -$34.4M | 0.04% | 573 |
|
|
2024
Q2 | $112M | Sell |
989,688
-51,270
| -5% | -$6.48M | 0.11% | 203 |
|
|
2024
Q1 | $144M | Buy |
1,040,958
+11,103
| +1% | +$1.4M | 0.14% | 156 |
|
|
2023
Q4 | $128M | Sell |
1,029,855
-4,737
| -0.5% | -$484K | 0.13% | 169 |
|
|
2023
Q3 | $96.5M | Buy |
1,034,592
+102,538
| +11% | +$11.6M | 0.11% | 225 |
|
|
2023
Q2 | $120M | Sell |
932,054
-10,596
| -1% | -$1.28M | 0.13% | 172 |
|
|
2023
Q1 | $110M | Sell |
942,650
-51,696
| -5% | -$5.79M | 0.12% | 201 |
|
|
2022
Q4 | $113M | Sell |
994,346
-231,047
| -19% | -$25.4M | 0.13% | 192 |
|
|
2022
Q3 | $98.7M | Sell |
1,225,393
-210,139
| -15% | -$17.8M | 0.12% | 225 |
|
|
2022
Q2 | $107M | Buy |
1,435,532
+393,260
| +38% | +$35.9M | 0.12% | 209 |
|
|
2022
Q1 | $126M | Buy |
1,042,272
+137,488
| +15% | +$15M | 0.13% | 192 |
|
|
2021
Q4 | $121M | Buy |
904,784
+69,552
| +8% | +$9.99M | 0.11% | 220 |
|
|
2021
Q3 | $114M | Sell |
835,232
-36,156
| -4% | -$4.56M | 0.11% | 220 |
|
|
2021
Q2 | $93M | Sell |
871,388
-52,964
| -6% | -$5.09M | 0.09% | 308 |
|
|
2021
Q1 | $83.1M | Sell |
924,352
-147,612
| -14% | -$13.9M | 0.09% | 331 |
|
|
2020
Q4 | $99.1M | Buy |
1,071,964
+204,848
| +24% | +$18.3M | 0.11% | 257 |
|
|
2020
Q3 | $89.4M | Sell |
867,116
-30,316
| -3% | -$3.17M | 0.11% | 233 |
|
|
2020
Q2 | $91M | Sell |
897,432
-273,968
| -23% | -$24.5M | 0.12% | 223 |
|
|
2020
Q1 | $78.9M | Buy |
1,171,400
+33,344
| +3% | +$2.07M | 0.13% | 212 |
|
|
2019
Q4 | $62.2M | Sell |
1,138,056
-951,636
| -46% | -$45.1M | 0.08% | 387 |
|
|
2019
Q3 | $78M | Buy |
2,089,692
+165,120
| +9% | +$6.41M | 0.1% | 285 |
|
|
2019
Q2 | $72.1M | Buy |
1,924,572
+186,920
| +11% | +$5.88M | 0.15% | 197 |
|
|
2019
Q1 | $51.7M | Sell |
1,737,652
-168,300
| -9% | -$5.91M | 0.12% | 253 |
|
|
2018
Q4 | $57.1M | Sell |
1,905,952
-105,888
| -5% | -$3.36M | 0.14% | 199 |
|
|
2018
Q3 | $71.9M | Buy |
2,011,840
+34,628
| +2% | +$1.07M | 0.15% | 191 |
|
|
2018
Q2 | $46.9M | Buy |
1,977,212
+1,974,288
| +67,520% | +$41.9M | 0.1% | 327 |
|
|
2018
Q1 | $54K | Sell |
2,924
-8
| -0.3% | -$118 | ﹤0.01% | 1740 |
|
|
2017
Q4 | $42K | Sell |
2,932
-543,200
| -99% | -$7.06M | ﹤0.01% | 1756 |
|
|
2017
Q3 | $6.68M | Sell |
546,132
-40,512
| -7% | -$716K | 0.02% | 774 |
|
|
2017
Q2 | $10.7M | Buy |
586,644
+48,540
| +9% | +$896K | 0.03% | 690 |
|
|
2017
Q1 | $11.4M | Sell |
538,104
-258,360
| -32% | -$5.04M | 0.03% | 680 |
|
|
2016
Q4 | $11.9M | Sell |
796,464
-872,196
| -52% | -$15.5M | 0.03% | 663 |
|
|
2016
Q3 | $36.6M | Buy |
1,668,660
+1,667,624
| +160,968% | +$37.1M | 0.1% | 341 |
|
|
2016
Q2 | $21K | Hold |
1,036
| – | – | ﹤0.01% | 1595 |
|
|
2016
Q1 | $18K | Hold |
1,036
| – | – | ﹤0.01% | 1619 |
|
|
2015
Q4 | $21K | Hold |
1,036
| – | – | ﹤0.01% | 1641 |
|
|
2015
Q3 | $22K | Hold |
1,036
| – | – | ﹤0.01% | 1579 |
|
|
2015
Q2 | $21K | Sell |
1,036
-14,364
| -93% | -$252K | ﹤0.01% | 1587 |
|
|
2015
Q1 | $240K | Hold |
15,400
| – | – | ﹤0.01% | 764 |
|
|
2014
Q4 | $212K | Buy |
+15,400
| New | +$189K | ﹤0.01% | 806 |
|
Other funds holding DXCM
Victory Capital Management's DXCM Position: Q2 2026 in Review
Victory Capital Management increased its DexCom (DXCM) stake by 12% in Q2 2026, buying an estimated $10.1M and bringing the position to 1,367,932 shares worth $92.1M. The position accounts for 0.05% of the portfolio, ranked #348.
Victory Capital Management first reported a position in DXCM in Q4 2014 and has held it in 47 quarters since. The position peaked at $144M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.
- Victory Capital Management held 1,367,932 shares of DexCom worth $92.1M as of Q2 2026.
- Victory Capital Management bought 151,327 DexCom shares in Q2 2026, an estimated $10.1M.
- DexCom made up 0.05% of Victory Capital Management's portfolio in Q2 2026, its #348 holding.
- Victory Capital Management first reported a position in DexCom in Q4 2014 and has held it in 47 quarters since.
- Victory Capital Management's DexCom position peaked at $144M in Q1 2024.
- 968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.
Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.